Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Chemokine receptor agonist CRIC-3 developed for allergic diseases

June 10, 2004

Niflumic acid, MSI-2216 block mucus expression in vitro

June 10, 2004

KF-19514 ameliorates asthma parameters in vivo

June 8, 2004

Anti-IL-13 antibody with potential for the treatment of asthma

June 8, 2004

Losartan reduces lung injury in preclinical studies

June 7, 2004

SD-208 shows promise in models of pulmonary fibrosis

June 7, 2004

New antihistaminic agents under study at Japan Energy

June 4, 2004

Antifibrotic effects of EM-703 studied in mice

June 4, 2004

ONO-EI-600 may offer protection against ventilator-induced lung injury

June 4, 2004

Activity of CAT-213 investigated in vitro and in vivo

June 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...